UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000011230 |
|---|---|
| Receipt number | R000013157 |
| Scientific Title | Phase II Clinical trial of personalized peptide vaccine for patients with maligant tumors (gastrointestinal cancers, hepato-biliary-pancreatic cancers, thoracic malignant tumors, non-epithelial malignant tumors, genitourinary cancers, gynecological cancers, breast cancers, and rare cancers) - Effect of extended interval dosing on immune responses - |
| Date of disclosure of the study information | 2013/07/23 |
| Last modified on | 2019/12/06 14:54:54 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/07/19 15:36:42 | ||
| 2 | Update | 2014/07/14 17:13:44 | Email |
|
| 3 | Update | 2014/12/12 12:22:15 | Key inclusion criteria Key inclusion criteria |
|
| 4 | Update | 2019/01/07 11:08:22 | Recruitment status |
|
| 5 | Update | 2019/12/06 14:54:54 | Recruitment status Date of IRB Last follow-up date |
